Ramsay Health Care Limited

RHCPA

Ramsay Health Care Ltd. is in the provision of healthcare services and the operation of hospitals and day surgery facilities. The company is headquartered in St Leonards, Victoria and currently employs 86,000 full-time employees. The Company’s segments include Asia Pacific, UK, France and Nordics. Its businesses include Ramsay Australia, Ramsay Sante, Ramsay UK, Elysium Healthcare and Ramsay Sime Darby. Ramsay Australia has over 73 private hospitals and day surgery units in Australia. Ramsay Sante is a private care provider in Europe and operates 443 multidisciplinary hospitals and clinics and 130 primary care centers across five countries. Ramsay UK has a network of 34 acute hospitals and day procedure centers in England providing a comprehensive range of clinical specialties to private and self-insured patients. Elysium Healthcare is an independent sector provider of specialist health and care services. Its four core service streams are mental health, neurological, learning disabilities and children and education.

Red Hill Minerals Limited

RHI

Red Hill Minerals Ltd. engages in the exploration of base metals, gold and iron ores properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-02-14. The firm is engaged in the exploration of iron ore, gold, and other minerals, including precious and base/battery metals. The firm is focused on the development of its channel iron deposits (CID) and rock quarrying opportunities in the Western Pilbara region of Western Australia. Its primary asset is Red Hill Iron Ore Joint Venture (RHIOJV). The firm holds a 100% interest in the Pannawonica channel iron project (CID), which is situated just north of the RHIOJV tenements. The firm has carried out studies for a quarrying concept based on porphyry rock outcrops at the Three Peaks site nearby to the Pannawonica Project.

Region Group

RGN

Region Group engages in the investment and management of shopping centres. The company is headquartered in Sydney, New South Wales. The company went IPO on 2012-11-26. The firm is engaged in investing in a geographically diverse portfolio of convenience-based retail centers. Its portfolio focuses on the non-discretionary retail sector (primarily convenience retailers and grocery outlets) and is anchored by long-term leases to tenants. The firm owns and manages approximately 91 convenience-based shopping centers. Its properties include Albury, Annandale Central, Auburn Central, AYR (Burdekin Plaza), Bakewell, Belmont Central, Bentons Square, Blakes Crossing, Brookwater Village, Burnie Plaza, Bushland Beach, Busselton, Cabarita, Cardiff, Carrara, Central Highlands (Emerald), Chancellor Park Marketplace, Claremont Plaza, Collingwood Park, Cooloola Cove, Currambine Central, Delacombe Town Centre, Drayton Central and more.

Regeneus Ltd

RGS

Regeneus Ltd. is regenerative medicine company. The firm uses stem cell technologies to develop a portfolio of novel cell-based therapies. The firm develops regenerative medicine products, including its two stem cell technologies, Progenza, which has been licensed to Kyocera for the treatment of knee osteoarthritis in Japan, and Sygenus, which is in pre-clinical-stage. Regenerative therapies seek to address unmet medical needs in the human health market, focusing on osteoarthritis, neuropathic pain, and various skin conditions, with its platform technologies Progenza and Sygenus. Progenza is a cellular therapy targeting pain and inflammation which uses Secretome to improve not only the resident tissue, but the Mesenchymal Signalling Cells (MSCs) themselves. Sygenus is a cell-free topical serum and gel treatment for pain and inflammation. Sygenus is a cell-free topical serum and gel treatment for pain and inflammation.